Clinical Trials on Choroidal Neovascularization (CNV) in Netherlands

Total 159 results

Novartis

Completed

Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Subfoveal Choroidal Neovascularization (CNV) | Secondary to Age-related Macular Degeneration (AMD)

Germany, Belgium, Spain, Netherlands, United Kingdom, Hungary, Turkey, Israel, Portugal, Australia
Novartis

Terminated

Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)

Macular Degeneration | Choroidal Neovascularization

United Kingdom, Spain, Netherlands, Hungary, Italy, Denmark, Belgium, Austria, France, Germany, Poland, Switzerland
Pfizer

Terminated

A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration

Age-Related Macular Degeneration

United States, United Kingdom, Australia, Netherlands
Martin Teraa, MD, PhD
ZonMw: The Netherlands Organisation for Health Research and Development

Unknown

Allogeneic Mesenchymal Stromal Cells for Angiogenesis and Neovascularization in No-option Ischemic Limbs (SAIL)

Cardiovascular Diseases | Vascular Diseases | Peripheral Arterial Disease

Netherlands
Maastricht University Medical Center

Completed

Contrast-enhanced Ultrasound (CE-US) and Magnetic Resonance Imaging (MRI): Evaluating Plaque Neovascularisation

Atherosclerosis | Carotid Artery Stenosis

Netherlands
Joost Daemen
Horizon 2020 - European Commission; REVA Medical, Inc.

Recruiting

FANTOM ENCORE Sirolimus-eluting Bioresorbable Scaffold for Treatment of De-novo CAD: the ENCORE-I Study

Percutaneous Coronary Intervention | Tomography, Optical Coherence | Myocardial Revascularization

Netherlands, Belgium
Nick van der Beek
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Active, not recruiting

Laser Induced Changes to Innervation and Vascularisation of Psoriatic Skin (LPA-01)

Psoriasis Vulgaris

Netherlands
Catharina Ziekenhuis Eindhoven

Terminated

Exercise Therapy With Risk Factor Management and Life Style Coaching After Vascular Intervention for Patients With Peripheral Arterial Disease (PEARL)

Peripheral Arterial Disease, Rutherford 4 and 5 With Possibility to Improve Vascularization

Netherlands
Radboud University Medical Center
Novo Nordisk A/S

Completed

Influence of Sutent on Tumor Vascularization and Necrosis in Patients With Renal Cell Carcinoma

Renal Cell Cancer

Netherlands
Erasmus Medical Center
Abbott; Pie Medical Imaging

Unknown

The FAST OCT Study

Coronary Arteriosclerosis | Unstable Angina | NSTEMI - Non-ST Segment Elevation MI | Tomography, Optical Coherence | Myocardial Revascularization | 3D-angio-based FFR

Netherlands
UMC Utrecht

Completed

Within Household Transmission of COVID-19 Infections (VERDI)

SARS-CoV-2

Netherlands
Delta Crystallon BV

Completed

Safety and Dose-finding Study of DC-TAB in Healthy Subjects

Multiple Sclerosis

Netherlands
University Medical Center Groningen

Not yet recruiting

TENS in Persons With MS

Multiple Sclerosis

Netherlands
University Medical Center Groningen
University of Groningen

Recruiting

The MS-CEBA Study: Determining Cognitive, Energetic, Behavioural and Affective (CEBA) Profiles in Multiple Sclerosis (MS-CEBA)

Multiple Sclerosis

Netherlands
Maastricht University Medical Center
Orbis Medical Centre

Completed

Vitamin D3 Supplementation and the T Cell Compartment in Multiple Sclerosis (MS)

Multiple Sclerosis

Netherlands
Amsterdam UMC, location VUmc

Recruiting

Multiple Sclerosis Self Monitoring Study (MSSM)

Multiple Sclerosis

Netherlands
Zuyderland Medisch Centrum
Radboud University Medical Center; Maastricht University Medical Center; Brno... and other collaborators

Recruiting

FFR Driven Complete Revascularization Versus Usual Care in NSTEMI Patients and Multivessel Disease (SLIM)

Coronary Artery Disease | Percutaneous Coronary Intervention | NSTEMI - Non-ST Segment Elevation MI | Myocardial Revascularization | Fractional Flow Reserve, Myocardial

Czechia, Netherlands, Hungary
Merck KGaA, Darmstadt, Germany
Merck Serono S.A., Geneva

Completed

An Observational Study for the Assessment of Adherence, Effectiveness and Convenience of Rebif® Treatment in Relapsing Multiple Sclerosis Patients Using RebiSmart™. (SMART)

Multiple Sclerosis, Relapsing-Remitting

Netherlands
Zuyderland Medisch Centrum
Scannexus

Active, not recruiting

Ultra-high-field Brain MRI in Multiple Sclerosis (ULTIMS)

Multiple Sclerosis

Netherlands
Zoé van Kempen

Completed

COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients (COMS-19)

Multiple Sclerosis

Netherlands
Amsterdam UMC, location VUmc
Stichting Treatmeds

Recruiting

Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS (Noisy Rebels)

Nervous System Diseases | Multiple Sclerosis | Demyelinating Autoimmune Diseases, CNS | Autoimmune Diseases of the Nervous System | Demyelinating Diseases | Multiple Sclerosis, Relapsing-Remitting

Netherlands
University Medical Center Groningen
ZonMw: The Netherlands Organisation for Health Research and Development

Recruiting

The Impact of the COVID-19 Pandemic on the Patient in Need of an Intervention (COVID Surg III)

COVID-19 | SARS-CoV-2 | Surgical Procedures, Operative

Netherlands
Amsterdam UMC, location VUmc

Completed

The Wearing-off Phenomenon of Ocrelizumab in Patients With Multiple Sclerosis (WOC)

Multiple Sclerosis

Netherlands
Amsterdam UMC, location VUmc
National MS Foundation, The Netherlands; Voeding Leeft

Recruiting

Lifestyle Intervention for Patients With Multiple Sclerosis (LIMS)

Multiple Sclerosis

Netherlands
Academic MS Center Limburg

Terminated

Vitamin D3 and the Stress-axis in MS

Multiple Sclerosis

Netherlands
Amsterdam UMC, location VUmc
Genzyme, a Sanofi Company; Universiteit Leiden; Personal Fitness Nederland; MS... and other collaborators

Recruiting

Don't be Late! Postponing Cognitive Decline and Preventing Early Unemployment in People With Multiple Sclerosis (DBL)

Multiple Sclerosis

Netherlands
Maastricht University Medical Center

Completed

Can the Electronic Nose Smell COVID-19?

Covid19 | SARS-CoV Infection

Netherlands
Maastricht University Medical Center

Completed

Can the Electronic Nose Smell COVID-19 Antibodies?

Covid19 | SARS-CoV Infection

Netherlands
Amsterdam UMC, location VUmc

Recruiting

Discontinuing Disease-modifying Therapies in Stable Relapsing - Onset Multiple Sclerosis (DOT-MS). (DOT-MS)

Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive

Netherlands
Amsterdam UMC, location VUmc
Erasmus Medical Center; St. Antonius Hospital; Rijnstate Hospital; OLVG; Prothya...

Completed

Towards Personalized Dosing of Natalizumab in Multiple Sclerosis (PDNMS)

Multiple Sclerosis

Netherlands
Amsterdam UMC, location VUmc

Recruiting

Clemastine Fumarate as Remyelinating Treatment in Internuclear Ophthalmoparesis and Multiple Sclerosis (RESTORE)

Multiple Sclerosis | Internuclear Ophthalmoplegia

Netherlands
Amsterdam UMC, location VUmc

Recruiting

B Cell Tailored Ocrelizumab Versus Standard Ocrelizumab in Relapsing Remitting Multiple Sclerosis (BLOOMS)

Multiple Sclerosis, Relapsing-Remitting

Netherlands
Isala

Active, not recruiting

Telemonitoring and Connected Care Applied to Multiple Sclerose (MonSter)

Multiple Sclerosis

Netherlands
Amphia Hospital
Sanofi; TEVA Pharmachemie

Unknown

Optical Coherence Tomography: Glatiramer in Clinically Isolated Syndrome or Early Relapsing Remitting Multiple Sclerosis (MS) (OCTIMS)

Multiple Sclerosis

Netherlands
BBB-Therapeutics B.V.

Terminated

Safety, Pharmacokinetics and Pharmacodynamics Study With 2B3-201 in Healthy Subjects and Multiple Sclerosis(MS) Patients

Multiple Sclerosis | Healthy Volunteers

Netherlands
UMC Utrecht
Sanquin Research & Blood Bank Divisions; National Institute for Public Health... and other collaborators

Recruiting

Prospective Monitoring of Antibody Response Following COVID-19 Vaccination in Patients With Down Syndrome. (PRIDE)

Down Syndrome | SARS-CoV-2 Vaccination

Netherlands
Azienda Ospedaliera Universitaria Integrata Verona
Charite University, Berlin, Germany; Institut National de la Santé Et de la... and other collaborators

Recruiting

Follow-up of Covid-19 Long Term Sequelae

Coronavirus Infections | Covid19 | Coronavirus Disease 2019 | Corona Virus Infection | Coronavirus | SARS-CoV2 Infection | COVID-19 Pneumonia | SARS-CoV-2 Acute Respiratory Disease | SARS (Severe Acute Respiratory Syndrome) | COVID-19 Respiratory Infection | SARS (Disease) | COVID-19 Acute Respiratory Distress... and other conditions

Italy, Belgium, Congo, France, Netherlands, Spain
Radboud University Medical Center
European Union

Completed

Safety and Tolerability of COVID-19 Vaccine (ABNCoV2) (COUGH-1)

Severe Acute Respiratory Syndrome | Covid19 | SARS-CoV-2 Infection

Netherlands
Radboud University Medical Center

Completed

Mucosal Immunity Against SARS-CoV-2 Infection in COVID-19 Patients (MuCo)

SARS-CoV-2 Infection

Netherlands
Jeroen Bosch Ziekenhuis

Terminated

AnaConDa-therapy in COVID-19 Patients

COVID-19 | SARS CoV-2

Netherlands
University Hospital Heidelberg
German Cancer Research Center

Recruiting

INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies (INFORM2 NivEnt)

Solid Tumor | CNS Tumor

France, Germany, Australia, Austria, Sweden, Netherlands, Switzerland
Biogen

Completed

Efficacy and Safety of BIIB111 for the Treatment of Choroideremia (STAR)

Choroideremia

United States, Finland, France, Denmark, Netherlands, Germany, United Kingdom, Canada
University Medical Center Groningen

Recruiting

Improving Social Cognition and Social Behaviour in Various Brain Disorders (T-ScEmo4ALL)

Stroke | Multiple Sclerosis | Brain Tumor

Netherlands
Hasselt University

Unknown

Effect of I-TRAVLE Training on Arm Function in MS and Chronic Stroke Patients

Multiple Sclerosis | Paralytic Stroke

Belgium, Netherlands
Amsterdam UMC, location VUmc
Netherlands Brain Foundation

Recruiting

Physical Training for People With Parkinson's Disease and Multiple Sclerosis: Effect on Mind and Body (HersenFIT)

Multiple Sclerosis | Parkinson Disease

Netherlands
University Medical Center Groningen

Completed

RECOVAC - Long Term Efficacy and Safety of COVID-19 (SARS-CoV-2) Vaccination in Kidney Disease Patients (LESS CoV-2)

Covid19 | Chronic Kidney Diseases | SARS-CoV Infection

Netherlands
Wellspect HealthCare

Terminated

Efficacy of Clean Intermittent Catheterization (CIC) in Multiple Sclerosis (MS) Patients With Bladder Dysfunction

Multiple Sclerosis | Bladder Dysfunction

Belgium, Netherlands, Germany, United Kingdom
Valneva Austria GmbH

Completed

VLA2001 Booster in Adult Participants After Priming With mRNA COVID-19 Vaccine and/or Natural SARS-CoV-2 Infection

SARS-CoV-2 Infection

New Zealand, Netherlands
Amsterdam UMC, location VUmc
GGZ inGeest; Parnassia Bavo Groep

Terminated

Online Cognitive Training in PD, MS and Depressed Patients Treated With Electroconvulsive Therapy

Multiple Sclerosis | Idiopathic Parkinson's Disease | Elderly Post Electric Convulsive Therapy

Netherlands
NightstaRx Ltd, a Biogen Company

Completed

Natural History of the Progression of Choroideremia Study (NIGHT)

Choroideremia

Finland, United States, Canada, Denmark, Netherlands, Germany, United Kingdom, Brazil, France

Clinical Trials on Choroidal Neovascularization (CNV) in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations